Why Thomas Massie's Ex-Girlfriend Came Forward With This Hush Money Story
Dem to Black Voters: We'd Screw You Over to Beat Republicans
The New York Times Might Regret Publishing That Column on Sexual Abuse in...
The Four Horsemen of the New Antisemitism
The Bipartisan Tax Relief Deal Is DOA Thanks to Wisconsin Democrats
Here's Why a Disabled Woman Is Suing the City of Portland
Gavin Newsom's 'Press Office' Responds to Inmate Tablet Scandal
Mike Johnson Warns That 'Little Mamdanis' Want to Build a Socialist Utopia in...
'Unprecedented Threat:' Routine Maintenance Found an IED at an Alabama Dam
How Did Memorial Drive Shooter Got Gun in Heavily Regulated Massachusetts?
Fentanyl Playground: LA Is a Walking Campaign Ad for Spencer Pratt
Jim Jordan Torches Fairfax Commonwealth Attorney Over Quiet Website Change on Immigration...
Fox News Got Firsthand Experience With China's Surveillance State. Here's What Happened.
Here's Why Marco Rubio Has Long Been a Proponent of NATO and Why...
Democrats Are on the Wrong Side of History With AI: Fetterman Rips Into...
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’
AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos